Trial intelligence / Profile preview

Effect of lidocaine, esmolol, and ketorolac on pain during rocuronium injection

IRCT20220719055498N1Phase 3Completed

Sponsor
Arak University of Medical Sciences
Start
Sep 2022
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of lidocaine, esmolol, ketorolac and rocuronium in procedural pain (3 arms), sponsored by Arak University of Medical Sciences. Started Sep 2022; status: completed.

02

Drugs

lidocaineesmololketorolacrocuronium
03

Conditions

procedural pain

Beyond the preview

Go deeper on IRCT20220719055498N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20220719055498N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call